Literature DB >> 30502050

Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype.

Faik Imeri1, Karen A Nolan1, Andreas M Bapst1, Sara Santambrogio1, Irene Abreu-Rodríguez1, Patrick Spielmann1, Svende Pfundstein1, Silvana Libertini1, Lisa Crowther1, Ilaria M C Orlando1, Sophie L Dahl1, Anna Keodara1, Willy Kuo1, Vartan Kurtcuoglu1, Carsten C Scholz1, Weihong Qi2, Edith Hummler3, David Hoogewijs1, Roland H Wenger4.   

Abstract

Erythropoietin (Epo) is essential for erythropoiesis and is mainly produced by the fetal liver and the adult kidney following hypoxic stimulation. Epo regulation is commonly studied in hepatoma cell lines, but differences in Epo regulation between kidney and liver limit the understanding of Epo dysregulation in polycythaemia and anaemia. To overcome this limitation, we have generated a novel transgenic mouse model expressing Cre recombinase specifically in the active fraction of renal Epo-producing (REP) cells. Crossing with reporter mice confirmed the inducible and highly specific tagging of REP cells, located in the corticomedullary border region where there is a steep drop in oxygen bioavailability. A novel method was developed to selectively grow primary REP cells in culture and to generate immortalized clonal cell lines, called fibroblastoid atypical interstitial kidney (FAIK) cells. FAIK cells show very early hypoxia-inducible factor (HIF)-2α induction, which precedes Epo transcription. Epo induction in FAIK cells reverses rapidly despite ongoing hypoxia, suggesting a cell autonomous feedback mechanism. In contrast, HIF stabilizing drugs resulted in chronic Epo induction in FAIK cells. RNA sequencing of three FAIK cell lines derived from independent kidneys revealed a high degree of overlap and suggests that REP cells represent a unique cell type with properties of pericytes, fibroblasts, and neurons, known as telocytes. These novel cell lines may be helpful to investigate myofibroblast differentiation in chronic kidney disease and to elucidate the molecular mechanisms of HIF stabilizing drugs currently in phase III studies to treat anemia in end-stage kidney disease.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anemia; cell signaling; erythropoietin; hypoxia

Mesh:

Substances:

Year:  2018        PMID: 30502050     DOI: 10.1016/j.kint.2018.08.043

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Effects of PHD and HSP90 on erythropoietin production in yak (Bos grunniens) renal interstitial fibroblast-like cells under hypoxia.

Authors:  Yan Cui; Hui Li; Si-Jiu Yu; Seth Yaw Afedo; Xue-Feng Bai
Journal:  J Mol Histol       Date:  2022-01-27       Impact factor: 2.611

Review 2.  The effect of HIF on metabolism and immunity.

Authors:  Cormac T Taylor; Carsten C Scholz
Journal:  Nat Rev Nephrol       Date:  2022-06-20       Impact factor: 42.439

3.  EPO synthesis induced by HIF-PHD inhibition is dependent on myofibroblast transdifferentiation and colocalizes with non-injured nephron segments in murine kidney fibrosis.

Authors:  Hanako Kobayashi; Olena Davidoff; Shiuli Pujari-Palmer; Malin Drevin; Volker H Haase
Journal:  Acta Physiol (Oxf)       Date:  2022-05-18       Impact factor: 7.523

4.  The HIFα-Stabilizing Drug Roxadustat Increases the Number of Renal Epo-Producing Sca-1+ Cells.

Authors:  Aline Jatho; Anke Zieseniss; Katja Brechtel-Curth; Jia Guo; Kai Oliver Böker; Gabriela Salinas; Roland H Wenger; Dörthe M Katschinski
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

5.  Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells.

Authors:  Redona Hafizi; Faik Imeri; Bisera Stepanovska Tanturovska; Roxana Manaila; Stephanie Schwalm; Sandra Trautmann; Roland H Wenger; Josef Pfeilschifter; Andrea Huwiler
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

6.  A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin.

Authors:  Jussi-Pekka Tolonen; Minna Heikkilä; Marjo Malinen; Hang-Mao Lee; Jorma J Palvimo; Gong-Hong Wei; Johanna Myllyharju
Journal:  Cell Mol Life Sci       Date:  2019-11-25       Impact factor: 9.261

7.  Neurogenic and pericytic plasticity of conditionally immortalized cells derived from renal erythropoietin-producing cells.

Authors:  Andreas M Bapst; Thomas Knöpfel; Karen A Nolan; Faik Imeri; Claus D Schuh; Andrew M Hall; Jia Guo; Dörthe M Katschinski; Roland H Wenger
Journal:  J Cell Physiol       Date:  2022-01-10       Impact factor: 6.513

8.  Fate-mapping of erythropoietin-producing cells in mouse models of hypoxaemia and renal tissue remodelling reveals repeated recruitment and persistent functionality.

Authors:  Sophie L Dahl; Svende Pfundstein; Rico Hunkeler; Xingtong Dong; Thomas Knöpfel; Patrick Spielmann; Carsten C Scholz; Karen A Nolan; Roland H Wenger
Journal:  Acta Physiol (Oxf)       Date:  2022-01-16       Impact factor: 7.523

Review 9.  Fount, fate, features, and function of renal erythropoietin-producing cells.

Authors:  Sophie L Dahl; Andreas M Bapst; Stellor Nlandu Khodo; Carsten C Scholz; Roland H Wenger
Journal:  Pflugers Arch       Date:  2022-06-24       Impact factor: 4.458

10.  Effect of Erythropoietin on Calcification of Vascular Smooth Muscle Cells and Its Molecular Regulatory Mechanism.

Authors:  Xunjia Li; Xushun Jiang; Fang He; Yunfeng Xia; Xuemei Chen; Xiaogang Du; Hua Gan
Journal:  J Cardiovasc Transl Res       Date:  2020-11-10       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.